NCT00121173View on ClinicalTrials.gov

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Cervical CancerPrecancerous Condition
Interventions
BIOLOGICAL

pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine

recombinant DNA vaccine

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00121173 - Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter